A 31-year-old manwhohad been under regular hemodialysis for 6 months was diagnosed as Williams syndrome (WS) by fluorescence in situ hybridization (FISH) chromosomal analysis. The association of WSand chronic renal failure (CRF) is only rarely encountered. Endocrinological examinations revealed hypergonadotropic hypogonadism. Prolonged and exaggerated responses of adrenocorticotropin (ACTH) to insulin-induced hypoglycemia and corticotropin releasing hormone (CRH) were also noted. While most of the endocrinological abnormalities observed in this patient could be attributed to altered endocrine circumstances in CRF, some findings stand in contrast. Furthermore, the testicular biopsy specimen showed severe hypospermatogenesis.
Introduction
Williams syndrome (WS) is a disease entity first described by Williams et al (1) and characterized as a developmental disorder involving the vascular, connective tissue and central nervous systems (2) (3) (4) . Features of this disorder include congenital heart disease, hypertension, premature aging of skin, dysmorphic facial features, infantile hypercalcemia, gregarious personality and mental retardation (3) . Recently, supravalvular aortic stenosis (SVAS), an inherited vascular disease as an autosomal dominant trait and a most common clinical feature of WS, has been proved to be caused by disruption of the elastin gene (5) (6) (7) (8) . Thereafter, Ewart et al (9) identified hemizygosity at the elastin locus in four familial and five sporadic cases of WSand demonstrated that WScould be caused by submicroscopic deletions within the chromosomal subunit 7q ll.23.
Preus (10) developed a diagnostic index capable of discriminating WSpatients from other dysmorphic, developmentally impaired children. Although short stature is recognized as one of the leading signs in WS (3, ll, 12) and is found in about 50%of children with WS (13) , detailed investigations on the hormonal regulation in patients with WShave not been performed. Recently, we treated a patient with chronic renal failure (CRF) who showed symptoms compatible with this syndrome;we were able to perform specific endocrinological evaluations on this patient. Wereport here a newvariant of WS associated with CRF and various endocrinological abnormalities.
Methods

Pituitary function assessments
Commercially available radioimmunoassay (RIA) kits were used to measure serum concentrations of pituitary hormones and cortisol as follows: For luteinizing hormone (LH) and follicle-stimulating hormone (FSH), Spac-S LH and FSH kit (Daiichi Radioisotope Lab, Tokyo); for growth hormone (GH), GHkit (Daiichi Radioisotope Lab); for adrenocorticotropin (ACTH), Allegro ACTHkit (Nihon Medi-Physics, Takarazuka); for thyrotropin (TSH), TSH RIABEADII kit (Dinabott, Tokyo); for prolactin (PRL), Spac-S PRL kit (Daiichi Radioisotope Lab); cortisol, y coat cortisol kit (Baxter Travenol Co., Tokyo mlU/ml (normal: 2.9-8.2 mlU/ml) levels, which was consistent with hypergonadotropic hypogonadism. Serum GHlevel was 28 ng/ml (normal: <0.42 ng/ml). Serum PRL was 91 ng/ml (normal: 1.5-9.7 ng/ml). Thyroid function showed free thyroxine (T4) level of 0.9 ng/dl (normal: 0.96-1.79 ng/dl), together with free triiodothyronine (T3), 3.0 pg/ml (normal: 2.47^.34 pg/ml) and TSH, 1.1 |iU/ml (normal: 0.34-3.5 jiU/ml) levels, strongly pointing to low T4 syndrome. Serum parathyroid hormone (PTH)-midportion (PTH-M) level was high (14 ng/ ml, normal: <0.8 ng/ml), possibly due to secondary hyperparathyroidism in CRF state (Table 2) . Pituitary hormone responses to provocation tests are shownin Table 3 . SerumLH and FSHshowed delayed and relatively low responses to LHreleasing hormone (LH-RH) (100 jag). Serum GH responses to insulin-induced hypoglycemia (regular insulin 0. 1 U/kg) were moderate, while serum GHresponses to GH-releasing factor (GRF) (100 jag) were prominent. Serum ACTHresponses to insulin-induced hypoglycemia (regular insulin 0. 1 U/kg) and corticotropin releasing hormone (CRH) ( 100 jig) showed prolonged exaggerated pattern of responses from high basal levels. Serum TSHresponses to thyrotropin releasing hormone (TRH) (500 jag) were impaired. SerumPRLresponses to TRH (500 |ig) showed no responses from high basal levels. Dynamic assessments for pituitary-adrenocortical function are shownin Table  4 . Serum ACTHand cortisol levels showed normal diurnal rhythm on both hemodialized and non-hemodialized day. Serum cortisol levels increased from 10.3 to 23.6 [ig/dl after rapid ACTHtest (1 24ACTH0.25 mg, i.v.). Testicular biopsy specimens revealed a part of atrophic and hyalinized seminiferous tubules. Remaining tubules were mildly dilated, however, spermatogenesis was still preserved (Fig. 3) . These findings suggest that the patient is infertile. (9) . The only SVAS mutation defined to date involves the 3' end of the elastin gene (8) , whereas all WS-associated deletions involve the entire gene. Based on these findings, they speculated that the specific elastin gene mutation, therefore, maybe responsible for some of the phenotypic differences between SVASand WS. Morimoto et al (14) performed molecular deletion analysis using two polymorphic markers of elastin gene in 10 Japanese patients with WS.Amongthem, one case with typical WSshowed two alleles, indicating that complete elastin gene was not deleted while partial deletion of elastin gene could not be ruled out, suggesting the possibility that partial deletion of the elastin gene might also be the pathogenesis of WS.Further molecular analysis in other WScases will help to clarify the exact pathogenesis of WS. In the present case, submicroscopic deletions of the elastin gene by FISH chromosomal analysis, together with the characteristic clinical features including SVAS led us to the diagnosis of WS. The exact cause ofCRFin the present case is obscure. When the patient was referred to our hospital, he was already suffering from severe chronic renal failure. Therefore further investigation on the cause of renal failure could not be performed. It is well knownthat patients with WSare often associated with hypertension (3), as is the case with the presentpatient. In recent reports (15) , hypertensive patients of varying ages with WS were found to have vascular anomalies, including renal artery stenosis, diffuse narrowing of the aorta, and discrete coarctation of the aorta occurring singly or together. It has been suggested that these vascular lesions are progressive (16) . Therefore, it is reasonable to consider that hypertension may be, at least in part, responsible for developing renal failure. Another possible cause is abnormal calcium metabolism. The significance of the hypercalcemia associated with WSshould be considered. Most patients have symptoms of hypercalcemia in both infancy (vomiting, constipation, and irritability) and adulthood (constipation, peptic ulcer, and frequent urination) (3). Ectopic calcifications and nephrocalcinosis also suggest a relative hypercalcemia. There is someevidence for abnormal clearance of serum calcium after an intravenous load (17, 18) , and hypercalcemia can be demonstrated in most patients (19) . Culler et al (18) have suggested that an error in calcitonin production or release mayresult in the relative hypercalcemia seen in WS. This relative hypercalcemia, in turn, may result in an increased calcium load to the kidneys and in polyuria. But, in the present case, nephrocalcinosis could not be observed and serum calcium level was within the normal limit. Therefore, the involvement of abnormal calcium metabolism in the progression of renal failure seemed to be unlikely.
The patient had no symptoms suggestive of pituitary or central nervous system lesions, skull X-rays and sella tomograms were normal, and he had never received medications knownto affect pituitary hormone secretion, suggesting that the abnormal patterns of pituitary hormone secretion maybe functional rather than structural. Endocrinological evaluations including the regulation of the hypothalamic-pituitary-gonadal axis and parameters of growth hormonesecretion have rarely been investigated in WS; little is knownabout pubertal development and fertility and the cause of short stature in this syndrome. To elucidate the hormonal regulation in children and adults with WS, Partsch et al (20) studied gonadotropins, sex and adrenal steroids, and insulin-like growth factors (IGFs) in numerous WSpatients of both sexes aged from infant to adulthood. The adult patients not only showed elevated basal LHand/or FSH levels but also pathologically elevated LH-RH-stimulated gonadotropin levels. Although all adults achieved full sexual maturation, the high percentage of decreased testicular volumesand the results of the LH-RHtests suggested a dysfunction of gonadal steroid production and spermatogenesis. On the other hand, almost all WSpatients showed normal IGF-1 levels, thus it may be deduced that GHsecretion is not severely disturbed and that GHdeficiency is not likely the cause of the short stature. While most of the endocrinological abnormalities noted in the present patient seemed to be in the same line with previously published data in CRFpatients, some findings are in contrast. CRFis associated with multiple metabolic abnormalities. Major importance amongthese abnormalities are disturbed hormonal relationships involving the pituitary gland and manyof its target organs. The circulating levels of a numberof anterior pituitary hormones are elevated in uremia. It has been established that the kidney plays an important role in the peripheral metabolism of low and medium molecular weight proteins, including many polypeptide hormones. Therefore, the reduced metabolic clearance rate maybe, at least in part responsible for hormonal abnormalities. Furthermore, dialysisassociated entities such as osteodystrophy, infection, negative nitrogen balance, hypertension and glucose intolerance maybe attributed in part to this abnormal state. Pituitary-testicular function revealed hypergonadotropic hypogonadism and the testicular biopsy specimen demonstrated severe spermatogenic damage.These abnormal findings in the pituitary-testicular axis have also been demonstrated in uremic patients by Holdsworth et al (21) . Studies of the reproductive status of men with severe CRF leading to HDhave established that spermatogenesis was impaired to degrees varying from a mild impairment of spermatogenesis to germinal cell aplasia. The mechanism of severe testicular damage in CRF remains to be fully elucidated. The middle-molecular weight protein breakdown products, the so-called uremic toxins, may be the mediator of spermatogenic damage. FSHserves as a marker of germinal epithelium function and plasma FSHlevels in general increase in parallel with damage to spermatogenesis, as seen in association with testicular damage from other causes (22, 23) . So, the feedback relationship between the seminiferous epithelium and FSHsecretion seems to remain intact in the presentpatient. Low serum testosterone levels suggest a deficiency in Leydig cell function. The elevated serum LHlevels, together with the low testosterone levels, suggest that due to this added stimulus testosterone production was not restored to normal. Thus, there are doubts that fertility is normal in this patient and it seems reasonable to speculate that testicular dysfunction, one of the clinical features of WS,was worsened by uremia in this patient. As for the GHsecretory pattern, the basal serum GHlevels were consistently high, while serum somatomedinC levels were within normal limits. GHresponded almost normally to GRF (100 jig) and insulin-induced hypoglycemia from high basal levels with delayed pattern. It has been well known that fasting GHlevels are elevated in children and adults with uremia (24) (25) (26) and that the rise is positively correlated with the degree of renal failure (27), however, it is not clear whether the elevation of GHlevels in uremia is primarily due to increased secretion or to diminished clearance of circulatory GH. Here, in hypothalamic-pituitary-adrenocortical function, the basal serum ACTHand cortisol levels were relatively high and showed normal diurnal rhythm on both hemodialized day and nonhemodialized day. Serum ACTHand cortisol responses to insulin-induced hypoglycemia and CRHwere augmented and prolonged. Serumcortisol responses to rapid ACTH administration showed normal responses, suggesting that the patient have normal adrenocortical function. To date, there has been no consistent data on basal serum ACTHand cortisol levels in CRF patients. Somedata showed normal serum levels and other show high levels. In addition, to date few data on provocation tests for hypothalamic-pituitary-adrenocortical axis are available. Kumagae (28) evaluated hypothalamic-pituitary-adrenocortical function with CRHin CRF patients under maintenance HD. In basal ACTHlevels, there was no significant difference between HDpatients and the normal controls. However, the ACTHsecretion to CRHwas blunted in HDpatients as compared to the controls. He speculated that blunted ACTH secretion to CRHin HDpatients was considered to be due to the negative feedback control by increased plasma cortisol. The pattern of response in the present patient was different from the data shown by Kumagae (28). In our patient, the basal ACTH level wasnot suppressed in spite of a moderate increase in the cortisol level and ACTHresponses to stimuli were exaggerated. One possible explanation is that CRHis excessively secreted, possibly due to chronic stress. The physiological significance of these abnormalities remains to be elucidated. Further investigations on hypothalamic-pituitary-adrenal axis in WSare necessary. Serum PRL responses to TRHshowed no responses from high basal levels. Similar patterns of responses have been well documented (29, 30). Since serum PRLis usually elevated in acute stressful situations (3 1), it is conceivable that uremia and maintenance HDmayconstitute a chronic stressful state and that hyperprolactinemia may be a consequential phenomenon. An abnormal PRLsecretory pattern could also result from an impaired renal excretion or degradation of PRL, an altered central nervous system inhibitory control due either to decreased secretion of a PRL-inhibiting factor (PIF) or to increased production of a PRL-releasing factor (PRF). An altered responsiveness of the pituitary lactotropes to central regulation maybe another cause. Thyroid function showeda pattern of low T4 syndrome. The reasons for the abnormal pituitary responsiveness to low thyroid hormonelevels and TRHare obscure and speculative. A defect in pituitary responsiveness to TRH maydevelop in renal failure, which is not reversed by renal transplantation (32). Intracellular thyroid hormone receptors in the pituitary may become saturated by the often supranormal free thyroid hormone levels found immediately after dialysis (33), and these maybe sufficient to maintain normal basal TSH levels and to suppress TSHresponses to TRHin some patients. An intra-thyroidal defect in hormonogenesis or hormone secretion probably also exists (34). Overall, the low T4 syndrome state noted in this patient may be a kind of adaptation for the low metabolic state in CRF. Although various endocrine disorders observed in this patient were modified to a larger extent by altered endocrine circumstances in CRF, some could not be explained by the CRF status alone. Careful endocrinological evaluation will give new insight to the better understanding of the clinical features of WS.
